224 related articles for article (PubMed ID: 31173838)
21. Comparison of cognitive performance in bipolar disorder, major depressive disorder, unaffected first-degree relatives, and healthy controls.
Bo Q; Dong F; Li X; Li F; Li P; Yu H; He F; Zhang G; Wang Z; Ma X; Wang C
Psychiatry Clin Neurosci; 2019 Feb; 73(2):70-76. PubMed ID: 30393945
[TBL] [Abstract][Full Text] [Related]
22. Empirical evidence for discrete neurocognitive subgroups in patients with non-psychotic major depressive disorder: clinical implications.
Pu S; Noda T; Setoyama S; Nakagome K
Psychol Med; 2018 Dec; 48(16):2717-2729. PubMed ID: 29679991
[TBL] [Abstract][Full Text] [Related]
23. Measuring cognitive function in MDD: emerging assessment tools.
Russo M; Mahon K; Burdick KE
Depress Anxiety; 2015 Apr; 32(4):262-9. PubMed ID: 25421437
[TBL] [Abstract][Full Text] [Related]
24. Cognitive impairment in major depressive disorder.
Pan Z; Park C; Brietzke E; Zuckerman H; Rong C; Mansur RB; Fus D; Subramaniapillai M; Lee Y; McIntyre RS
CNS Spectr; 2019 Feb; 24(1):22-29. PubMed ID: 30468135
[TBL] [Abstract][Full Text] [Related]
25. A Systematic Review and Meta-Analysis of Cognitive Training in Adults with Major Depressive Disorder.
Woolf C; Lampit A; Shahnawaz Z; Sabates J; Norrie LM; Burke D; Naismith SL; Mowszowski L
Neuropsychol Rev; 2022 Jun; 32(2):419-437. PubMed ID: 33913064
[TBL] [Abstract][Full Text] [Related]
26. Preliminary evidence concerning the pattern and magnitude of cognitive dysfunction in major depressive disorder using cogstate measures.
Davis MT; DellaGioia N; Matuskey D; Harel B; Maruff P; Pietrzak RH; Esterlis I
J Affect Disord; 2017 Aug; 218():82-85. PubMed ID: 28460315
[TBL] [Abstract][Full Text] [Related]
27. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions.
McIntyre RS; Cha DS; Soczynska JK; Woldeyohannes HO; Gallaugher LA; Kudlow P; Alsuwaidan M; Baskaran A
Depress Anxiety; 2013 Jun; 30(6):515-27. PubMed ID: 23468126
[TBL] [Abstract][Full Text] [Related]
28. The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.
McIntyre RS; Xiao HX; Syeda K; Vinberg M; Carvalho AF; Mansur RB; Maruschak N; Cha DS
CNS Drugs; 2015 Jul; 29(7):577-89. PubMed ID: 26290264
[TBL] [Abstract][Full Text] [Related]
29. Automated Neuropsychological Test Battery in depression -- preliminary data.
Egerházi A; Balla P; Ritzl A; Varga Z; Frecska E; Berecz R
Neuropsychopharmacol Hung; 2013 Mar; 15(1):5-11. PubMed ID: 23542754
[TBL] [Abstract][Full Text] [Related]
30. Cognitive factor structure and measurement invariance between healthy controls and patients with major depressive disorder.
Yang KC; Hsieh WC; Chou YH
J Psychiatr Res; 2022 Jul; 151():598-605. PubMed ID: 35636038
[TBL] [Abstract][Full Text] [Related]
31. Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives.
Salagre E; Solé B; Tomioka Y; Fernandes BS; Hidalgo-Mazzei D; Garriga M; Jimenez E; Sanchez-Moreno J; Vieta E; Grande I
J Affect Disord; 2017 Oct; 221():205-221. PubMed ID: 28651185
[TBL] [Abstract][Full Text] [Related]
32. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
[TBL] [Abstract][Full Text] [Related]
33. Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers.
Harrison JE; Barry H; Baune BT; Best MW; Bowie CR; Cha DS; Culpepper L; Fossati P; Greer TL; Harmer C; Klag E; Lam RW; Lee Y; Mansur RB; Wittchen HU; McIntyre RS
Int J Methods Psychiatr Res; 2018 Sep; 27(3):e1736. PubMed ID: 30088298
[TBL] [Abstract][Full Text] [Related]
34. Similar profiles of cognitive domain deficits between medication-naïve patients with bipolar II depression and those with major depressive disorder.
Liu T; Zhong S; Wang B; Liao X; Lai S; Jia Y
J Affect Disord; 2019 Jan; 243():55-61. PubMed ID: 30227315
[TBL] [Abstract][Full Text] [Related]
35. Cognitive remission: a novel objective for the treatment of major depression?
Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF
BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406
[TBL] [Abstract][Full Text] [Related]
36. [Cognition - the core of major depressive disorder].
Polosan M; Lemogne C; Jardri R; Fossati P
Encephale; 2016 Feb; 42(1 Suppl 1):1S3-11. PubMed ID: 26879254
[TBL] [Abstract][Full Text] [Related]
37. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
[TBL] [Abstract][Full Text] [Related]
38. Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management.
Culpepper L; Lam RW; McIntyre RS
J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505194
[TBL] [Abstract][Full Text] [Related]
39. Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder.
Bakkour N; Samp J; Akhras K; El Hammi E; Soussi I; Zahra F; Duru G; Kooli A; Toumi M
Psychiatry Res; 2014 May; 216(3):291-302. PubMed ID: 24656516
[TBL] [Abstract][Full Text] [Related]
40. Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies.
Murrough JW; Iacoviello B; Neumeister A; Charney DS; Iosifescu DV
Neurobiol Learn Mem; 2011 Nov; 96(4):553-63. PubMed ID: 21704176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
